Refractory autoimmune haemolytic anaemia following allogenic haematopoietic stem cell transplantation: successful treatment of rituximab
Objective To investigate the effectiveness and safety of rituximab in treating autoimmune haemolytic anaemia (AIHA) after allogeneic haematopoietic stem cell transplantation (allo-HSCT). Methods Patients with refractory AIHA following allo-HSCT were treated once-weekly with rituximab 375 mg/m 2 for...
Main Authors: | Xiaofan Li, Jiafu Huang, Zhijuan Zhu, Nainong Li |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-07-01
|
Series: | Journal of International Medical Research |
Online Access: | https://doi.org/10.1177/0300060519855593 |
Similar Items
-
Hard-To-Treat Idiopathic Refractory Autoimmune Haemolytic Anaemia with Reticulocytopenia
by: Marcelo Aveiro, et al.
Published: (2020-12-01) -
Autoimmune Haemolytic Anaemia and Multiple Autoimmune Syndrome
by: Mohammad Mahdi Adib Sereshki, et al.
Published: (2019-04-01) -
rare cause of recurrent haemolytic anaemia: carboplatin and paclitaxel-induced autoimmune haemolytic anaemia
by: Pitchaporn Yingchoncharoen, et al.
Published: (2023-02-01) -
Antibodies to actin in autoimmune haemolytic anaemia
by: Ritzmann Mathias, et al.
Published: (2010-03-01) -
The effect of HLA matching and donor relatedness on the risk of autoimmune haemolytic anaemia in haematopoietic stem cell transplant recipients: A systematic review and meta‐analysis
by: Cassandra Kennedy, et al.
Published: (2022-08-01)